Molecularly Imprinted Polymer Nanoparticles for Lung-Cancer-Cell-Surface Proteomics.

Kirabo Magumba, Elena Piletska, Thong Huy Cao, Donald Jones, Salvador Macip, Sergey Piletsky

Abstract read

In one paragraph

Article in Polymers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kirabo MagumbaSchool of Chemistry, College of Science and Engineering, University of Leicester, Leicester LE2 7RH, UK.

Elena PiletskaSchool of Chemistry, College of Science and Engineering, University of Leicester, Leicester LE2 7RH, UK.

Thong Huy CaoLeicester van Geest MultiOMICs Facility, University of Leicester, Leicester LE3 9QP, UK.ORCID 0000-0002-6559-0836

Donald JonesLeicester van Geest MultiOMICs Facility, University of Leicester, Leicester LE3 9QP, UK.ORCID 0000-0001-6583-870X

Salvador MacipMechanisms of Cancer and Aging Laboratory, Division of Molecular and Cell Biology, University of Leicester, Leicester LE1 7RH, UK.ORCID 0000-0003-1963-8840

Sergey PiletskySchool of Chemistry, College of Science and Engineering, University of Leicester, Leicester LE2 7RH, UK.ORCID 0000-0003-2052-5763

Funding

University of Leicester Future 100

6 · The paper itself

Abstract

The identification and targeting of lung-cancer-cell-surface proteins are important for drug development. Molecularly imprinted polymer nanoparticles (nanoMIPs) offer a synthetic approach for the recognition of proteins on the cell surfaces. This work outlines the use of a novel 'snapshot imprinting' approach to characterize differences in the cell-surface proteomes of lung cancer cell lines (A549, H460, H522) and a non-cancerous cell line (BEAS-2B) to potential protein targets for diagnostic and therapeutic applications. The mass spectrometry-based quantitative proteomics identified 2381 proteins. Fold change and

Indexed as

lung cancermolecularly imprinted polymer nanoparticlesprotein targetsproteomics

Identifiers

PMID41599577

DOI10.3390/polym18020281

PMCPMC12845741

What Socratic holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.